Sinovation (Beijing) Medical Technology Co., Ltd.

Sinovation (Beijing) Medical Technology Co., Ltd. is dedicated to the research, manufacturing, and technical services of intelligent innovative medical devices. As a leading enterprise in neurosurgical innovative medical devices in China, it provides comprehensive technological and product solutions for the treatment of brain diseases.  Sinovation Medical has been honored with various accolades, including being recognized as a national high-tech enterprise and a national intellectual property advantage enterprise.

Sinovation Medical has independently developed nine products that have obtained Class III medical device registration certificates from the National Medical Products Administration (NMPA), with four of them approved through the special review channel for innovative medical devices. It has formed five major product lines, including the neurosurgical robot SR series, miniature neurosurgical robot Q300 series, neurosurgical navigation system NS series, intracranial electrode series, and magnetic resonance-guided laser ablation therapy system LS series. These products serve over 200 medical institutions nationwide, with the intracranial electrodes and neurosurgical robots ranking among the top in the domestic market share. Furthermore, the neurosurgical robot Sinobot X1 has also been appoved by the U.S. Food and Drug Administration (FDA), making it the only Chinese neurosurgical robotic system to obtain FDA approval.